Kawasaki-like disease increase in Italian COVID-19 epicenter | 2 Minute Medicine
Differentiating factors between Kawasaki disease and SoJIA | Download Table
Atypical Kawasaki Disease Secondary to Streptococcal pyogenes | American Academy of Pediatrics
Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches | SpringerLink
Kawasaki disease - Wikipedia
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population – topic of research paper in Clinical medicine. Download scholarly article PDF and
Kawasaki Disease Clinic - Stanford Children's Health
Top PDF Macrophage activation syndrome (MAS) - 1Library
2014 ACR/ARHP Annual Meeting: Macrophage Activation Syndrome - The Rheumatologist
Frontiers | Kawasaki Disease Complicated With Macrophage Activation Syndrome: Case Reports and Literature Review | Pediatrics
Kawasaki disease - Journal of the American Academy of Dermatology
Kawasaki Disease: Heart Disease During Childhood | Revista Española de Cardiología
KD Parent Symposium 2020 - YouTube
VisualAbstract: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic | 2 Minute Medicine
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet
Macrophage Activation Syndrome - The Rheumatologist
Adenosine Deaminase 2 as a Circulating Biomarker of Macrophage Activation Syndrome - ACR Meeting Abstracts
Pregunte a los expertos de KD: Puntuaciones de la enfermedad de Kawasaki & Z Fundación para la Enfermedad de Kawasaki
Prolonged Fever and Intravenous Immunoglobulin Resistance in Kawasaki Disease: Should Macrophage Activation Syndrome Be Considered? | Iranian Journal of Pediatrics | Full Text
Eric Topol on Twitter: "Just out @TheLancet: The children with Kawasaki disease from #SARSCoV2 A unique report from Italy comparing this to pre-#COVID19: the incidence has gone up 30-fold and it is
Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant | BMJ Case Reports
CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Macrophage Activation Syndrome in SJIA - Alexei Grom
